Location History:
- Edison, NJ (US) (1999 - 2002)
- Annandale, NJ (US) (2010)
Company Filing History:
Years Active: 1999-2010
Title: Chung-Her Jenh: Innovator in Pharmaceutical Chemistry
Introduction
Chung-Her Jenh is a notable inventor based in Annandale, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 5 patents, showcasing his innovative approach to drug development and therapeutic solutions.
Latest Patents
One of his latest patents involves pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity. This application discloses a compound, including its enantiomers, stereoisomers, and other derivatives, aimed at treating chemokine-mediated diseases. The patent outlines methods for addressing various conditions such as inflammatory diseases, autoimmune diseases, and tumors using the disclosed compounds. Another significant patent focuses on the design, cloning, and expression of humanized monoclonal antibodies against human interleukin-5. This invention includes a hybridoma that produces the monoclonal antibody and various pharmaceutical compositions that utilize this antibody for therapeutic purposes.
Career Highlights
Throughout his career, Chung-Her Jenh has worked with prominent companies in the pharmaceutical industry, including Schering Corporation and Pharmacopeia Inc. His work has significantly impacted the development of new therapeutic agents and treatment methodologies.
Collaborations
Chung-Her Jenh has collaborated with esteemed colleagues such as Paul J Zavodny and Chuan-Chu Chou, contributing to advancements in their respective fields.
Conclusion
Chung-Her Jenh's innovative work in pharmaceutical chemistry and his numerous patents highlight his dedication to improving healthcare through scientific research and development. His contributions continue to influence the industry and pave the way for future advancements.